|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Paralytic and diarrhoeic shellfish poisons: occurrence in Europe, toxicity, analysis and regulation显示文摘 | VAN EGMOND H P AUNE T LASSUS P | 1993 | J Nat Toxins1993，2，： | 1 |
| 2 | Ezrin immunoreacflvlty in relation to survival in serious ovarian patients显示文摘 | Moilanen J Lassus H Leminen A et at | 2003 | Gynecol oneol2003，90，2： | 1 |
| 3 | Gene amplification,mutation and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma显示文摘 | Lassus H Sihto H Leminen A | 2006 | J Mol Med2006，84，8： | 1 |
| 4 | Ezrin immunoreactlvlty in relation to survival in serious ovarian patients显示文摘 | Moilanen J Lassus H Leminen A | 2003 | Gynecol oneol2003，90，2： | 1 |
| 5 | Glycodelin in ovarian serous carcinoma:association with differentiation and survival显示文摘 | Lassus H Sep pala M | 2003 | Cancer Res2003，63，19： | 1 |
| 6 | Ezrin immunoreaetivity in relationship to survival in serous ovarian carcinoma patients显示文摘 | Moilanen J Lassus H Leminen A | 2003 | Gynecol Oncol2003，90，2： | 1 |
| 7 | Elevated cyclooxygnease-2 expression is associated with altered expression of P53 and Smad4,amplification of HER-2/neu and poor outcome in serous ovarian carcinoma显示文摘 | Erkinheimo TL Lassus H Finne P | 2004 | Clin cancer Res2004，10，2： | 1 |
| 8 | ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma显示文摘 | Lassus H Leminen A Vayrynen A | 2004 | Gynecol Oncol2004，92，1： | 1 |
| 9 | Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 19q22-q23distal to SMAD4,SMAD2,and DCC显示文摘 | Salovaara R Aahonen LA | 2001 | Am J Pathology2001，159，： | 1 |
| 10 | Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients显示文摘 | LASSUS H LEMINEN A | 2003 | Gynecol Oncol2003，90，2： | 1 |
| 11 | A thermoelectric sensor for fluid flow measurement显示文摘 | Stachowiak H Lassue A | 1998 | Flow Meas Instrum1998，9，3： | 1 |
| 12 | Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous o- varian carcinoma显示文摘 | Lassus H Sihto H Leminen A | 2006 | J Mol Med2006，84，8： | 1 |
| 13 | Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor lociat19q22-q23 distal to SMAD4,SMAD2,andDCC 显示文摘 | Lassus H Salovaara R Aaltonen LA | 2001 | Am J Pathology2001，159，： | 1 |
| 14 | Comparison of serous and muicinous ovarian carcinomas: Distinct pattern of alleliic loss at distal 8p and expression of transcription factor GATA-4 显示文摘 | Lassus H Laitinen MP Anttonen M | 2001 | Lab In- vest2001，81，： | 1 |
| 15 | Comparison of serous and mucinous ovarian arcinomas:distinct pattern of allelic loss atdistal 18p and expression of transcription factor GATA-4 显示文摘 | Lassus H Laitinen MP Anttonen M | 2001 | Lab Invest2001，81，： | 1 |
| 16 | Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4,amplification of HER-2/neu,and poor outcome in serous ovarian carcinoma显示文摘 | Lassus H Finne P | 2004 | Clin Cancer Res2004，10，2： | 1 |
| 17 | Glycodelin in ovarian serous carcinoma:association with differentiation and survival显示文摘 | Lassus H Seppala M | 2003 | Cancer Res2003，63，19： | 1 |
| 18 | Distinct expression levelsand patterns of stem cell markers,aldehyde dehydrogenaseisoforms 1(ALDH1),in human epithelial cancers显示文摘 | Deng S Yang X Lassus H | 2010 | PLoS ONE2010，5，10： | 1 |
| 19 | Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients显示文摘 | MOILANEN J LASSUS H LEMINEN A | 2003 | Gynecol Oncol2003，90，2： | 1 |
| 20 | Ezrin immunore- activity in relation to survival in serous ovarian carcinoma patienls显示文摘 | Moilanen J Lassus H Leminen A | 2003 | Gynecol Oncol2003，90，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员